Monoclonal Antibody and Oral Antiviral Treatment of SARS-CoV-2 Infection in US Nursing Homes
Authors:
- 8 August 2023
- journal article
- letter
- Published by American Medical Association (AMA) in JAMA
- Vol. 330 (6) , 561-563
Abstract
This study examines the use of COVID-19 antiviral treatments in US nursing homes and the facility characteristics associated with use of oral antivirals and monoclonal antibodies.Keywords
This publication has 2 references indexed in Scilit:
- Evolving Real-World Effectiveness of Monoclonal Antibodies for Treatment of COVID-19Annals of Internal Medicine, 2023
- Effectiveness of nirmatrelvir–ritonavir in preventing hospital admissions and deaths in people with COVID-19: a cohort study in a large US health-care systemThe Lancet Infectious Diseases, 2023